Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
May 11, 2023
Tickers
OPTHF
Tags
Good Manufacturing Practices
Psychedelic/Assisted Therapies
Market News
From
Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
Tickers
ATAI
CMPS
Tags
Penny Stocks
News
Psychedelic/Assisted Therapies
From
Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
Tags
multiple sclerosis
Benzinga
Psychedelics
From
Benzinga
Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
May 10, 2023
Tickers
SILO
Tags
Ketamine Treatment
Markets
Cannabis
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
Psychedelic/Assisted Therapies
CYBN
Markets
From
Benzinga
Legal Magic Mushroom Therapy Now Available In Oregon, But Are Prices Too Steep?
May 09, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist
May 08, 2023
Tags
Cannabis
Markets
Market News
From
Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
Tickers
CMND
CMPS
HUGE
IWINF
Tags
Global
Psychedelic/Assisted Therapies
Markets
From
Benzinga
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
May 07, 2023
Tickers
COPHF
Tags
News
PTSD
Psychedelics
From
Benzinga
Oregon Certifies First Psychedelics-Assisted Therapy Center In The Nation
May 05, 2023
Tags
Market News
Measure 109
Markets
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
Psychedelic/Assisted Therapies
Guidance
LSD Therapy
From
Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
May 05, 2023
Tags
WIPO
Terran Biosciences
Benzinga
From
Benzinga
Washington State County Decriminalizes Psychedelics, Gov. Calls For Special Session On Drug Policy
May 04, 2023
Tags
Psychedelics
Psychedelics Reform
News
From
Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
May 03, 2023
Tags
Psychedelic/Assisted Therapies
Psilocybin program
Market News
From
Benzinga
Colorado's Rapidly-Progressing Measure For Legal Psychedelics Regulation Heads To Gov.'s Desk
May 03, 2023
Tags
Psychedelic/Assisted Therapies
Markets
Cannabis
From
Benzinga
Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction
May 03, 2023
Tickers
CMND
Tags
Psychedelics
News
psychedelic compound MEAI
From
Benzinga
Psychedelics Reform Update: Arizona's MDMA Gets Gov's Signature, California, Minnesota & Missouri's Progress
May 02, 2023
Tags
Psychedelics Reform
News
Psychedelics
From
Benzinga
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
May 02, 2023
Tickers
CMPS
JNJ
Tags
MAPS PBC
FDA
Psychedelics
From
Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
Tags
Benzinga Cannabis Insider
Psychedelics
Interview
From
Benzinga
Colorado Takes Another Step In Psychedelics Regulation As Amended Bill Receives Approval
April 26, 2023
Tags
Benzinga
Psychedelics Colorado
General
From
Benzinga
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued
April 26, 2023
Tags
Psychedelic/Assisted Therapies
Oregon Psilocybin Services
Guidance
From
Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
April 26, 2023
Tickers
MSSTF
Tags
General
Psychedelics
intellectual property
From
Benzinga
Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed
April 25, 2023
Tickers
REUN
Tags
Psychedelics
REUN
NASDAQ
From
Benzinga
New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings
April 25, 2023
Tickers
MYCOF
Tags
MYCOF
Psychedelics
PTSD
From
Benzinga
Can AI Foster Research And Psychedelics Therapy Without Replacing Human Connection?
April 24, 2023
Tags
News
AI Psychedelics
Sam Altman
From
Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
CMND
Penny Stocks
MNMD
From
Benzinga
Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals
April 21, 2023
Tags
Psychedelics Reform
General
Psychedelics
From
Benzinga
Psychedelics Therapy For Teens, Elders, And Borderline Disorder Patients: Here Are The Latest Findings
April 21, 2023
Tags
Benzinga
Older Adults Psychedelics
Legal
From
Benzinga
Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
April 20, 2023
Tickers
CMND
Tags
Cannabis
Markets
Market News
From
Benzinga
Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up
April 20, 2023
Tickers
LOBEF
Tags
Benzinga
Rare Diseases
Top Stories
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.